Fine excipient materials in carrier-based dry powder inhalation formulations: The interplay of particle size and concentration effects

被引:0
|
作者
Elsayed, Mustafa M. A. [1 ,2 ]
Alfagih, Iman M. [3 ]
Brockbank, Katrina [4 ]
Alheibshy, Fawaz [1 ]
Aodah, Alhassan H. [5 ]
Ali, Raisuddin [3 ]
Almansour, Khaled [1 ]
Shalash, Ahmed O. [6 ]
机构
[1] Univ Hail, Coll Pharm, Dept Pharmaceut, Hail, Saudi Arabia
[2] Alexandria Univ, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt
[3] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia
[4] Freeman Technol Ltd, Tewkesbury, England
[5] King Abdulaziz City Sci & Technol KACST, Adv Diagnost & Therapeut Inst, Hlth Sect, Riyadh, Saudi Arabia
[6] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia
关键词
Dry powder inhalation; Carrier; Fine excipient material; Quality-by-design (QbD); Critical material attributes; Powder rheology; Mixing energy; SALMETEROL XINAFOATE; ADHESIVE MIXTURES; LACTOSE FINES; PERFORMANCE; SURFACE; DISPERSION; DETACHMENT; TIME;
D O I
10.1016/j.ijpx.2024.100251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The contributions of fine excipient materials to drug dispersibility from carrier-based dry powder inhalation (DPI) formulations are well recognized, although they are not completely understood. To improve the understanding of these contributions, we investigated the influences of the particle size of the fine excipient materials on characteristics of carrier-based DPI formulations. We studied two particle size grades of silica microspheres, with volume median diameters of 3.31 mu m and 8.14 mu m, as fine excipient materials. Inhalation formulations, each composed of a lactose carrier material, one of the fine excipient materials (2.5% or 15.0% w/w), and a drug (fluticasone propionate) material (1.5% w/w) were prepared. The physical microstructure, the rheological properties, the aerosolization pattern, and the aerodynamic performance of the formulations were studied. At low concentration, the large silica microspheres had a more beneficial influence on the drug dispersibility than the small silica microspheres. At high concentration, only the small silica microspheres had a beneficial influence on the drug dispersibility. The results reveal influences of fine excipient materials on mixing mechanics. At low concentration, the fine particles improved deaggregation and distribution of the drug particles over the surfaces of the carrier particles. The large silica microspheres were associated with a greater mixing energy and a greater improvement in the drug dispersibility than the small silica microspheres. At high concentration, the large silica microspheres kneaded the drug particles onto the surfaces of the carrier particles and thus impaired the drug dispersibility. As a critical attribute of fine excipient materials in carrier-based dry powder inhalation formulations, the particle size demands robust specification setting.
引用
收藏
页数:11
相关论文
共 41 条
  • [31] CARRIER-BASED DRY POWDER INHALATION PART II: IMPACT OF CARRIER MATERIAL AND API PROCESSING ON THE INTER-PARTICULATE SURFACE INTERACTIONS IN ADHESIVE MIXTURES FOR INHALATION
    Zellnitz, S.
    Faulhammer, E.
    Wahl, V.
    Schroettner, H.
    Khinast, J. G.
    Paudel, A.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (03) : A10 - A11
  • [32] An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances
    Jones, Matthew D.
    Harris, Haggis
    Hooton, Jennifer C.
    Shur, Jagdeep
    King, Graeme S.
    Mathoulin, Camilla A.
    Nichol, Katrina
    Smith, Tracey L.
    Dawson, Michelle L.
    Ferrie, Alan R.
    Price, Robert
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (02) : 496 - 507
  • [33] DEM analysis of the effect of particle-wall impact on the dispersion performance in carrier-based dry powder inhalers
    Yang, Jiecheng
    Wu, Chuan-Yu
    Adams, Michael
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 487 (1-2) : 32 - 38
  • [34] Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems
    Ooi, Jesslynn
    Traini, Daniela
    Hoe, Susan
    Wong, William
    Young, Paul M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 413 (1-2) : 1 - 9
  • [35] Effect of Sampling Inhalation Volume on Evaluation of Dispersion and Deposition Performance of a Carrier-based Dry Powder Inhaler by Three Different Impactors
    Lu, Huanhuan
    Wu, Fei
    Chen, Lan
    Chen, Donghao
    Chinese Journal of Pharmaceuticals, 2023, 54 (01) : 101 - 110
  • [36] Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology
    Tse, Jun Yee
    Kadota, Kazunori
    Imakubo, Tetsuya
    Uchiyama, Hiromasa
    Tozuka, Yuichi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 156
  • [37] In vitro evaluation of dry powder inhalers .2. Influence of carrier particle size and concentration on in vitro deposition
    Steckel, H
    Muller, BW
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) : 31 - 37
  • [38] Dry powder inhaler delivery of amorphous drug nanoparticles: Effects of the lactose carrier particle shape and size
    Rho, Katherine
    Hadinoto, Kunn
    POWDER TECHNOLOGY, 2013, 233 : 303 - 311
  • [39] Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
    Benke, Edit
    Farkas, Arpad
    Szabo-Revesz, Piroska
    Ambrus, Rita
    PHARMACEUTICS, 2020, 12 (06) : 1 - 19
  • [40] Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation
    Zeng, XM
    Martin, GP
    Tee, SK
    Abu Ghoush, A
    Marriott, C
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (02) : 133 - 144